Federal drug conspiracy prosecutions can involve dozens of defendants, multiple suppliers, numerous customers and years of alleged drug transactions.
But knowing people who distribute drugs does not automatically make someone a member of their conspiracy.
Under 21 U.S.C. § 846, the government must prove that the defendant knowingly agreed to participate in the criminal agreement charged in the indictment. This distinction becomes especially important when prosecutors attempt to characterize several separate drug relationships as one large conspiracy.
What Must the Government Prove in a Federal Drug Conspiracy?
A drug conspiracy requires an agreement between two or more people to violate federal drug law.
The government does not need a written agreement. A conspiracy can be proved through circumstantial evidence.
But association with drug dealers, knowledge of their activities, or presence around criminal conduct does not by itself establish that a defendant joined their conspiracy.
The central question is whether the evidence proves beyond a reasonable doubt that the defendant knowingly agreed to participate in the unlawful venture.
United States v. Chandler and the Eleventh Circuit
An important Eleventh Circuit decision addressing the limits of conspiracy liability is United States v. Chandler, 388 F.3d 796 (11th Cir. 2004).
Chandler was involved in a promotional scheme involving McDonald’s game pieces. Although it was not a drug prosecution, its discussion of conspiracy law is particularly useful in cases where the government attempts to combine numerous individuals into a single conspiracy.
The Eleventh Circuit emphasized that a conspiracy requires an agreement.
It is not enough for several people to deal with the same central person separately.
There must be evidence permitting the jury to find that the participants agreed to participate in the larger criminal objective charged by the government.
The Hub and Spoke Problem
One way of understanding this issue is the hub-and-spoke conspiracy.
Imagine one central drug supplier as the hub of a wheel.
The supplier separately sells drugs to Dealer A, Dealer B and Dealer C.
Those dealers are the spokes.
The fact that all three dealers obtain drugs from the same supplier does not necessarily establish that Dealers A, B, and C agreed to participate together in one overall conspiracy.
There must be evidence linking the spokes to the broader criminal objective.
Without that connection, the evidence may establish separate conspiracies involving the central supplier rather than the single overarching conspiracy charged in the indictment.
Knowledge Is Not the Same as Agreement
This distinction is particularly important in large federal drug prosecutions.
A defendant may know that his supplier sells drugs to many other people.
He may even know the identities of some of those people.
That knowledge does not necessarily establish that he agreed to participate in their activities.
The government must prove the defendant’s agreement to participate in the charged conspiracy.
Knowledge of a larger criminal operation is not automatically an agreement to join it.
Single Conspiracy or Multiple Conspiracies?
Federal indictments frequently charge defendants with participating in a single conspiracy lasting months or years.
The evidence at trial may tell a different story.
Instead of a single unified conspiracy, the evidence may reveal several independent agreements involving different people, transactions, and objectives.
Courts examining whether the evidence supports a single conspiracy consider the nature of the alleged agreement and the relationships among the participants.
The existence of a common supplier or central participant does not necessarily answer the question.
The government must establish the agreement charged in the indictment.
What Is a Variance?
A variance can occur when the indictment charges one conspiracy, but the evidence at trial proves multiple conspiracies.
That distinction matters because a defendant is entitled to be tried for the offense charged by the grand jury.
But proving a variance does not automatically require reversal of a conviction.
The defense generally must also establish that the variance substantially prejudiced the defendant.
Spillover Prejudice in a Large Drug Trial
Prejudice can become particularly serious in a multi-defendant conspiracy trial.
Suppose the government introduces evidence concerning hundreds of kilograms of cocaine, firearms, violence, large amounts of cash, and recorded conversations involving major drug traffickers.
A defendant at the edge of the case may have had nothing to do with much of that conduct.
If the evidence actually establishes several separate conspiracies rather than the single conspiracy charged, there is a danger that the jury will transfer evidence concerning one group of defendants to another.
This is sometimes described as spillover prejudice.
The defense should therefore identify precisely which evidence actually relates to the particular defendant and which evidence concerns criminal activity committed by others.
Buyer-Seller Relationships Present a Related Issue
Drug conspiracy cases frequently involve another important question: whether the evidence establishes a conspiracy or merely a buyer-seller relationship.
A drug transaction necessarily requires some agreement between a buyer and a seller.
That agreement alone does not automatically establish a separate agreement to participate together in a broader drug distribution conspiracy.
However, repeated transactions, distribution quantities, and other surrounding circumstances may provide evidence from which a jury can infer a conspiratorial agreement.
The analysis is highly dependent on the facts.
The critical question remains whether the government proved the defendant knowingly joined the conspiracy charged.
Drug Quantity Can Dramatically Affect the Case
The scope of the alleged conspiracy can have enormous consequences in a federal drug prosecution.
Federal drug statutes establish different penalties depending upon the type and quantity of controlled substances involved.
Drug quantity can also substantially affect the advisory Sentencing Guidelines.
For that reason, the defense should distinguish between the existence of a conspiracy and the scope of the criminal activity attributable to the individual defendant.
Those are related questions, but they are not necessarily the same.
Conspiracy Membership Does Not Make Every Drug Quantity Relevant Conduct
A particularly important limitation appears in U.S.S.G. § 1B1.3, the Sentencing Guidelines provision governing relevant conduct.
A defendant convicted of conspiracy is not automatically responsible at sentencing for every drug transaction committed by every member of the conspiracy.
For the conduct of another person to qualify as relevant conduct based on jointly undertaken criminal activity, the conduct must be:
Within the scope of the criminal activity, the defendant agreed to jointly undertake
In furtherance of that criminal activity
Reasonably foreseeable in connection with that criminal activity
The first requirement is critical.
The scope of a defendant’s jointly undertaken criminal activity is not necessarily the same as the scope of the entire conspiracy.
Knowledge of Other Drug Activity Is Not Enough at Sentencing
The Sentencing Guidelines provide an especially useful example.
Suppose a defendant agrees to distribute 500 grams of cocaine for a major drug trafficker. The defendant knows that the trafficker is involved in importing much larger quantities.
That knowledge does not automatically make the defendant responsible for all of the trafficker’s cocaine.
If the defendant’s agreement and conduct were limited to the 500 grams, the Guidelines explain that the defendant may be accountable only for that amount rather than the much larger quantity involved in the overall operation.
This principle can make an enormous difference in calculating the advisory Guidelines.
The Court Must Determine the Scope of the Defendant’s Agreement
At sentencing, it is therefore not enough to say:
The defendant joined the conspiracy, and all of these drugs were reasonably foreseeable.
The analysis must first determine the scope of the criminal activity the particular defendant agreed to undertake jointly.
Only after determining that scope does the court consider whether another participant’s conduct was in furtherance of that jointly undertaken activity and reasonably foreseeable.
This prevents the government from automatically converting knowledge of a large drug operation into sentencing responsibility for the entire operation.
Co-Conspirator Statements Can Also Depend on the Conspiracy
The scope and existence of the alleged conspiracy can also affect the evidence admitted at trial.
Under Federal Rule of Evidence 801(d)(2)(E), certain statements made by a defendant’s co-conspirator during and in furtherance of a conspiracy are not treated as hearsay.
That rule can allow the government to introduce damaging statements made outside the defendant’s presence.
But the government cannot simply label everyone a co-conspirator and thereby admit every statement made by every person associated with the case.
The existence of the conspiracy, the defendant’s participation, and whether the statement was made during and in furtherance of the conspiracy remain important questions.
Defending a Federal Drug Conspiracy Case
A federal drug conspiracy defense should examine the government’s theory defendant by defendant and transaction by transaction.
Important questions include:
What exactly did the defendant agree to do?
Who did the defendant allegedly agree with?
Does the evidence establish one conspiracy or several separate conspiracies?
Does the evidence establish only a buyer-seller relationship?
Did the defendant know about the broader organization without agreeing to participate in it?
Is there evidence concerning other defendants being improperly attributed to this defendant?
What drug quantity actually falls within the scope of the defendant’s jointly undertaken criminal activity?
Are cooperating witnesses expanding the defendant’s role to obtain favorable treatment from the government?
These questions can affect guilt, admissibility of evidence, and sentencing.
Contact Federal Drug Conspiracy Defense Attorney Michael J. Petro
Federal drug conspiracy cases can expose defendants to evidence concerning criminal conduct committed by numerous other people.
The government must still prove that the particular defendant knowingly joined the charged conspiracy.
And even after a conspiracy conviction, the government cannot automatically attribute every drug transaction committed by every conspirator to an individual defendant for purposes of relevant conduct.
Michael J. Petro represents defendants charged with federal drug offenses and federal drug conspiracies.
Charged as part of a federal drug conspiracy involving other defendants? Call federal criminal defense attorney Michael J. Petro to examine the government’s conspiracy, drug quantity, and relevant conduct evidence.